Skip to content

Philip Tagari

  • MA
  • Executive Director Research
  • Amgen Inc
  • 0ReadersNumber of instances of Philip's publications in Mendeley libraries. Updated daily.
  • 20PublicationsNumber of items in Philip's My Publications folder on Mendeley.

Research interests

Protein medicinal chemistry Neuroscience Structural biology Biophysics Membrane proteins

About

Over 25 years of research experience in the areas of neurobiology, hematology/oncology, metabolic disease, immunology & inflammation, cell and molecular biology, peptide chemistry, analytical chemistry & biochemistry, structural biology, pharmacokinetics, safety pharmacology, laboratory automation and information technologies, leading to several important experimental and marketed therapies and over 65 peer-reviewed publications. Strong executive experience including: multi-facility management (>100 FTE, $10M budget); pipeline review; product & technology licensing; merger/acquisition and venture

Followers (2)

Following (1)

Publications (5)

  • Discovery of novel hydroxy-thiazoles as HIF-alpha prolyl hydroxylase inhibitors: SAR, synthesis, and modeling evaluation.

    • Tegley C
    • Viswanadhan V
    • Biswas K
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • Effects of COX-2 Inhibitors on Aortic Prostacyclin Production in Cholesterol-fed Rabbits

    • Wong, E, Huang JQ, Tagari P R
    N/AReaders
    N/ACitations
  • Measurement of canine urinary thromboxanes by GC-MS and HPLC-RIA.

    • Tagari P
    • Callaghan D
    • Black C
    • et al.
    N/AReaders
    N/ACitations
  • Cholinerigic and Gabaergic Neurotoxicity of some Alkylating Agents

    • Maysinger, Dusica, Tagari, Philip, Cuello C
    N/AReaders
    N/ACitations
  • Leukotriene D4 receptor blockade inhibits the immediate and late bronchoconstrictor responses to inhaled antigen in patients with asthma

    • Jørgen Bo Rasmussen, Lars-Olof Eriksson, Dorothy J. Margolskee, Philip Tagari, Vanessa C. Williams K
    N/AReaders
    N/ACitations

Professional experience

Executive Director Research

Amgen, Inc.

August 1998 - Present

Research Fellow

Merck & Co

December 1987 - August 1998(11 years)

Education history

MA

Gonvile & Caius College, Cambridge UK

September 1976 - June 1979(3 years)